Get the Stockscreener App
32.68
4.30%
-1.47
Veracyte Inc stock is traded at $32.68, with a volume of 697.40K.
It is down -4.30% in the last 24 hours and up +5.42% over the past month.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
See More
Previous Close:
$34.15
Open:
$33.89
24h Volume:
697.40K
Relative Volume:
0.49
Market Cap:
$2.57B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-43.57
EPS:
-0.75
Net Cash Flow:
$40.13M
1W Performance:
+2.67%
1M Performance:
+5.42%
6M Performance:
-1.45%
1Y Performance:
-3.11%
1-Day Range:
$32.34
$34.14
1-Week Range:
$32.09
$34.89
52-Week Range:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
32.68 | 2.69B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
468.00 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
185.91 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
627.17 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.38 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.24 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Initiated | Craig Hallum | Buy |
| Dec-05-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025 - BioSpace
Veracyte to present first prospective data on hormone therapy biomarker By Investing.com - Investing.com South Africa
Veracyte, Inc. Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented At Astro 2025 - MarketScreener
First-Ever Hormone Therapy Response Predictor: Veracyte's Groundbreaking Prostate Cancer Study at ASTRO 2025 - Stock Titan
Strs Ohio Makes New Investment in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (NASDAQ:VCYT) SVP Annie Mcguire Sells 2,283 Shares - MarketBeat
Exchange Traded Concepts LLC Purchases 23,047 Shares of Veracyte, Inc. $VCYT - MarketBeat
Assenagon Asset Management S.A. Increases Stake in Veracyte, Inc. $VCYT - MarketBeat
Price Action: Can 374Water Inc be recession proofMarket Activity Report & Safe Entry Momentum Stock Tips - خودرو بانک
Short Covering: What is the dividend yield of Veracyte IncTrade Entry Report & Smart Investment Allocation Insights - خودرو بانک
Market Rankings: What is the Moat Score of AMN Healthcare Services IncSwing Trade & Daily Technical Forecast Reports - خودرو بانک
Market Trends: Is Veracyte Incs ROIC above industry averageEarnings Recap Summary & Free Real-Time Volume Trigger Notifications - خودرو بانک
Aug Intraday: Is Veracyte Inc a strong candidate for buy and holdJuly 2025 Closing Moves & Stepwise Swing Trade Plans - خودرو بانک
Is Veracyte Inc. trending in predictive chart modelsJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Can momentum traders help lift Veracyte Inc.Market Volume Summary & Consistent Return Investment Signals - newser.com
Aug Summary: Is Ondas Holdings Inc forming a bullish divergenceEarnings Risk Report & Verified Technical Trade Signals - khodrobank.com
AQR Capital Management LLC Sells 34,410 Shares of Veracyte, Inc. $VCYT - MarketBeat
RSI Check: Is Veracyte Inc. a turnaround storyJuly 2025 Trade Ideas & Risk Controlled Daily Trade Plans - khodrobank.com
Is Veracyte Incs ROIC above industry average2025 Earnings Impact & Stepwise Trade Signal Guides - خودرو بانک
Exit strategy if you’re trapped in Veracyte Inc.Portfolio Return Summary & Safe Entry Momentum Tips - newser.com
Day Trade: Should I buy SPYU stock nowNew Guidance & Consistent Growth Stock Picks - خودرو بانک
Great Lakes Advisors LLC Sells 21,107 Shares of Veracyte, Inc. $VCYT - MarketBeat
Growth Report: Can Traeger Inc disrupt its industryTrade Performance Summary & Low Drawdown Trading Strategies - خودرو بانک
MACD Signal: Is Veracyte Inc a strong candidate for buy and holdMarket Trend Report & Intraday High Probability Alerts - خودرو بانک
Aug Patterns: What are the future prospects of Veracyte IncWeekly Gains Summary & Verified Momentum Watchlists - خودرو بانک
Whale Trades: Can Peoples Financial Services Corp. ride the EV wave2025 Retail Activity & Smart Allocation Stock Tips - خودرو بانک
Does Veracyte Inc. fit your quant trading modelMarket Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
AQR Capital Management LLC Lowers Stock Position in Veracyte, Inc. $VCYT - Defense World
Veracyte (NASDAQ:VCYT) CEO Marc Stapley Sells 7,667 Shares - MarketBeat
Is Veracyte Inc. still worth holding after the dip2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Can trapped investors hope for a rebound in Veracyte Inc.Trade Entry Summary & Low Risk Entry Point Tips - Newser
Will Veracyte Inc. stock go up soonQuarterly Trade Summary & High Yield Stock Recommendations - Newser
Real time scanner hits for Veracyte Inc. explainedEntry Point & Low Risk Entry Point Tips - Newser
Tools to monitor Veracyte Inc. recovery probabilityJuly 2025 Trends & Risk Managed Investment Signals - Newser
Price momentum metrics for Veracyte Inc. explainedQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Will earnings trigger a reversal in Veracyte Inc.July 2025 WrapUp & Free Daily Entry Point Trade Alerts - Newser
Bridgeway Capital Management LLC Sells 41,300 Shares of Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. $VCYT Shares Purchased by Parkman Healthcare Partners LLC - MarketBeat
Veracyte (VCYT) Valuation in Focus as Groundbreaking Prostate Cancer Study Drives Clinical Adoption and Pipeline Progress - Sahm
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
Transcript : Veracyte, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 04 - MarketScreener
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation - Investing.com India
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting - Business Wire
Veracyte CEO Stapley sells $233k in shares By Investing.com - Investing.com South Africa
Veracyte CEO Stapley sells $233k in shares - Investing.com India
Can Veracyte Inc. expand into new marketsWeekly Stock Report & Low Drawdown Momentum Trade Ideas - beatles.ru
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):